SCLX (STOCKS)
Scilex Holding Company Common Stock
$6.110000
-0.690000 (-10.15%)
Prev close: $6.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Henry H. Ji
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49.93M
- Employees
- 31
- P/E (TTM)
- -0.16
- P/B (TTM)
- -0.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2025 (Q2)
|
$-3.79 | $-0.93 | -2.8618 | -308.32% |
|
Mar 2025 (Q1)
|
$-2.26 | $-1.25 | -1.0105 | -80.87% |
|
Dec 2024 (Q4)
|
$0.00 | $-6.96 | +6.9615 | +100.00% |
|
Sep 2024 (Q3)
|
$-1.05 | $-5.95 | +4.9001 | +82.35% |
Financial Statements
| Revenues | $30.25M |
| Benefits Costs and Expenses | $404.28M |
| Cost Of Revenue | $10.60M |
| Costs And Expenses | $404.28M |
| Gross Profit | $125.80M |
| Nonoperating Income/Loss | -$28.02M |
| Operating Expenses | $471.81M |
| Selling, General, and Administrative Expenses | $266.88M |
| Research and Development | $20.71M |
| Other Operating Expenses | $184.21M |
| Operating Income/Loss | -$346.01M |
| Income/Loss Before Equity Method Investments | -$428.79M |
| Income/Loss From Continuing Operations After Tax | -$374.05M |
| Income/Loss From Continuing Operations Before Tax | -$374.03M |
| Income/Loss From Equity Method Investments | $54.76M |
| Income Tax Expense/Benefit | $26.00K |
| Income Tax Expense/Benefit, Current | $26.00K |
| Income Tax Expense/Benefit, Deferred | $13.57M |
| Net Income/Loss | -$362.25M |
| Net Income/Loss Attributable To Noncontrolling Interest | $11.80M |
| Net Income/Loss Attributable To Parent | -$374.05M |
| Net Income/Loss Available To Common Stockholders, Basic | -$402.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $28.43M |
| Preferred Stock Dividends And Other Adjustments | $28.43M |
| Basic Earnings Per Share | -$36.48 |
| Diluted Earnings Per Share | -$36.48 |
| Basic Average Shares | 11,034 |
| Diluted Average Shares | 11,034 |
| Assets | $364.98M |
| Current Assets | $38.36M |
| Inventory | $4.79M |
| Other Current Assets | $33.57M |
| Noncurrent Assets | $326.62M |
| Fixed Assets | $13.60M |
| Intangible Assets | $59.09M |
| Other Non-current Assets | $253.94M |
| Liabilities | $576.73M |
| Current Liabilities | $483.65M |
| Accounts Payable | $86.27M |
| Other Current Liabilities | $397.39M |
| Noncurrent Liabilities | $93.08M |
| Equity | -$211.75M |
| Equity Attributable To Noncontrolling Interest | -$3.97M |
| Equity Attributable To Parent | -$207.78M |
| Liabilities And Equity | $364.98M |
| Net Cash Flow From Operating Activities | $3.82M |
| Net Cash Flow From Operating Activities, Continuing | $3.80M |
| Net Cash Flow From Investing Activities | $4.08M |
| Net Cash Flow From Investing Activities, Continuing | $4.08M |
| Net Cash Flow From Financing Activities | -$5.46M |
| Net Cash Flow From Financing Activities, Continuing | -$5.46M |
| Exchange Gains/Losses | -$756.00K |
| Net Cash Flow | $1.68M |
| Net Cash Flow, Continuing | $2.42M |
| Comprehensive Income/Loss | -$370.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$370.85M |
| Other Comprehensive Income/Loss | -$12.12M |